UFP Technologies, Inc. (UFPT) is a Healthcare stock trading at $304.60 (as of 2026-08-20), with a market capitalization of $2.36B and a trailing P/E of 34.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
UFP Technologies designs and custom manufactures components, subassemblies, products, and packaging using specialized foams, films, and plastics, with a focus on medical single-use and single-patient devices and related wound care, infection prevention, and surgical applications. It also engineers products for automotive, aerospace and defense, consumer, electronics, and industrial customers, selling primarily through a direct sales force and independent representatives in the United States.
UFP Technologies designs and custom-manufactures specialized foam, film, and plastic components and packaging for medical device customers, and it also sells engineered products and components to non-medical markets.
Because UFP builds custom components and packaging from specialized foams, films, and plastics for medical devices, its profit model depends on converting customer requirements for single-use and single-patient products into repeat manufacturing and supply orders, with medical mix providing the majority of sales.
| Medical | $0.1B |
| Non-Medical | $0.0B |
| Other | $0.1B |
Business quality (Mixed): The company is clearly tied to medical device supply and custom manufacturing, but the available operating indicators emphasize non-medical demand weakness and only limited unfilled incremental orders.
Valuation: At 25× earnings, UFPT trades 24% below the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $304.60 |
| Market Cap | $2.36B |
| P/E Ratio | 34.5 |
| EV / EBITDA | 21.9 |
| Price / Book | 5.37 |
| Price / Sales | 3.88 |
| FCF Yield | 1.9% |
| DCF Value (model) | $121.44 |
| DCF Upside vs Price | -60.1% |
| Revenue (TTM) | $602.80M |
| Net Margin | 11.3% |
| Revenue Growth (YoY) | 19.5% |
| EPS Growth (YoY) | 15.3% |
| Altman Z-Score | 8.51 (safe) |
| Piotroski F-Score | 7/9 (strong) |
| Stock P/E | 34.5 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 59.9% |
| vs Industry | 5.0% |
| Top Institutional Holder | BlackRock, Inc. ($212.41M) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | R. Jeffrey Bailly |
| Employees | 4,146 |
| Country | US |
| IPO Date | 1993-12-17 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.